Modulight (MODU) Q3 2024 earnings summary
Event summary combining transcript, slides, and related documents.
Q3 2024 earnings summary
19 Jan, 2026Executive summary
Q3 2024 revenue increased 58% year-over-year to EUR 640 thousand, though it declined 34% sequentially; nine-month revenue was EUR 2,664 thousand, down 11% year-over-year.
EBITDA loss narrowed by 50% in Q3 to EUR -1,278 thousand, reflecting improved operational efficiency and reduced one-time costs.
The pay-per-treatment (PPT) business model expanded to new customers and continents, with accelerated device deployments in Australia and the U.S.
R&D pipeline stable at 30 projects, with focus on phase III trials, commercialization, and successful prototype deliveries, including to a major quantum computing company.
Cash flow from operations and net cash flow improved significantly year-over-year, supported by the completion of a major investment program and a strong cash position of EUR 18.5 million at period end.
Financial highlights
Q3 2024 revenue: EUR 640 thousand (+58% YoY, -34% QoQ); nine-month revenue: EUR 2,664 thousand (-11% YoY).
Q3 EBITDA: EUR -1,278 thousand (improved from -2,537 thousand); nine-month EBITDA: EUR -3,813 thousand (improved from -5,547 thousand).
Q3 EBIT: EUR -2,108 thousand (improved from -3,074 thousand); nine-month EBIT: EUR -6,134 thousand (improved from -7,072 thousand).
EPS for Jan–Sep 2024: EUR -0.13 (improved from -0.16); Q3 EPS: EUR -0.05 (improved from -0.07).
Cash and cash equivalents at period end: EUR 18,531 thousand; net debt: EUR -13,523 thousand.
Outlook and guidance
Revenue forecasting remains challenging due to early-stage customer projects and macroeconomic/geopolitical uncertainties; no guidance provided for 2024.
Strategic focus on transitioning to the PPT business model, commercial rollouts, and geographic expansion, with most revenue expected to accumulate in 2025.
Continued investment in R&D and expansion, with new customers signed in Asia and ongoing focus on the U.S. market.
Latest events from Modulight
- Record revenue growth and improved profitability, driven by PPT model and project expansion.MODU
Q4 202520 Feb 2026 - Q2 2024 revenue fell 13% YoY, but EBITDA loss narrowed and cash flow improved as the pipeline grew.MODU
Q2 202423 Jan 2026 - Revenue up 52% and EBITDA up 56%, driven by US growth and pay-per-treatment expansion.MODU
Q1 202524 Dec 2025 - Q4 revenue up 40% YoY, cash flow and margins improved as PPT model reached 50 hospitals.MODU
Q4 202424 Dec 2025 - Q2 revenue doubled and EBITDA neared zero as the pipeline and global customer base expanded.MODU
Q2 202523 Nov 2025 - Revenue up 176% YoY, losses narrowing, and PPT business driving strong operational gains.MODU
Q3 202531 Oct 2025